KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) Interest & Investment Income (2018 - 2025)

Historic Interest & Investment Income for Castle Biosciences (CSTL) over the last 8 years, with Q3 2025 value amounting to $2.8 million.

  • Castle Biosciences' Interest & Investment Income fell 1677.44% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.2 million, marking a year-over-year decrease of 327.73%. This contributed to the annual value of $12.9 million for FY2024, which is 2158.52% up from last year.
  • Per Castle Biosciences' latest filing, its Interest & Investment Income stood at $2.8 million for Q3 2025, which was down 1677.44% from $2.9 million recorded in Q2 2025.
  • Castle Biosciences' 5-year Interest & Investment Income high stood at $3.4 million for Q3 2024, and its period low was $4000.0 during Q1 2021.
  • Its 5-year average for Interest & Investment Income is $1.9 million, with a median of $2.4 million in 2023.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first plummeted by 9865.77% in 2021, then surged by 1328235.29% in 2022.
  • Over the past 5 years, Castle Biosciences' Interest & Investment Income (Quarter) stood at $17000.0 in 2021, then soared by 13282.35% to $2.3 million in 2022, then surged by 37.1% to $3.1 million in 2023, then rose by 8.11% to $3.4 million in 2024, then dropped by 15.98% to $2.8 million in 2025.
  • Its last three reported values are $2.8 million in Q3 2025, $2.9 million for Q2 2025, and $3.1 million during Q1 2025.